|Articles|April 20, 2021
Liposomal and Nanoparticle Technology
Author(s)Pfizer CentreOne
Specializing in oncology, anti-infective and complex formulations, Pfizer CentreOne provides end to end services from development through to commercial manufacture of sterile dosage forms.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
How ten23 health is Advancing Patient-Centric Drug Delivery
2
FDA, Duke University Planning Epinephrine Access Workshop for December
3
METHONOVA™: Enhancing Cell Culture Growth and Productivity with High Purity Methylcellulose
4
Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II
5
